Longtime Peninsula biotech seeks $200M as stock soars on strength of heart drug trial
The company's stock soared more than 40% Monday as it said it will take a heart drug into a late-stage clinical trial.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: American Health | Biotechnology | Cardiology | Clinical Trials | Health Management | Heart